| Literature DB >> 15589831 |
M C Monti1, A Casapullo, R Riccio, L Gomez-Paloma.
Abstract
25-Acetyl-petrosaspongiolide M (PMAc) (1), a mild non-covalent PLA(2) inhibitor, unexpectedly recovers, after incubation with bvPLA(2), the ability to covalently modify the enzyme target. This study demonstrates the catalytic effect of bvPLA(2) in converting 1 in its deacetylated congener petrosaspongiolide M (PM) (2), a strong covalent PLA(2) inhibitor whose molecular mechanism of inhibition has already been clarified. Moreover, our findings outline the potential role of PMAc as anti-inflammatory pro-drug, by virtue of its ability of delivering the active PM agent at the site of inflammation, functioning as a suicide inhibitor.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15589831 DOI: 10.1016/j.febslet.2004.10.100
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124